Myeloma cells can promote osteoclastic activity rather than osteoclast recruitment in vitro; Evidence from the 5T2MM murine model of myeloma

Myeloma cells can promote osteoclastic activity rather than osteoclast recruitment in vitro; Evidence from the 5T2MM murine model of myeloma

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Mueller, G, Vanderkerken, K, Russell, R, Croucher, P
التنسيق:	Conference item
منشور في:	2004

مواد مشابهة

5T2MM murine myeloma cells and CD138+ve human myeloma cells promote osteoclastic activity rather than osteoclast formation in vitro
حسب: Mueller, G, وآخرون
منشور في: (2004)

The Role of Myeloma Cells to Osteoclast Activation
حسب: Bahare Sadeghi, وآخرون
منشور في: (2010-01-01)

Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease
حسب: Ersek, A, وآخرون
منشور في: (2015)

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.
حسب: Shipman, C, وآخرون
منشور في: (2000)

Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.
حسب: Edwards, C, وآخرون
منشور في: (2007)

Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease
حسب: Leng, H
منشور في: (2019)

An In Vitro Model of Murine Osteoclast-Mediated Bone Resorption
حسب: Xiaoyue Sun, وآخرون
منشور في: (2024-11-01)

APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.
حسب: Croucher, P, وآخرون
منشور في: (2002)

Osteoprotegerin and the development of myeloma bone disease
حسب: Croucher, P, وآخرون
منشور في: (2004)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
حسب: Mabilleau, G, وآخرون
منشور في: (2009)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.
حسب: Mabilleau, G, وآخرون
منشور في: (2009)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.
حسب: Guillaume Mabilleau, وآخرون
منشور في: (2009-01-01)

Zoledronic Acid Inhibits the Capacity of Myeloid-Immune Suppressor Cells in Myeloma to Form Osteoclasts.
حسب: Zhuang, J, وآخرون
منشور في: (2008)

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation
حسب: Dongzheng Gai, وآخرون
منشور في: (2022-09-01)

Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1
حسب: Yu-Tzu Tai, وآخرون
منشور في: (2018-08-01)

Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells
حسب: Tibullo eDaniele, وآخرون
منشور في: (2015-10-01)

Bisphosphonates and in vivo models of multiple myeloma - Reply
حسب: Shipman, C, وآخرون
منشور في: (2001)

Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
حسب: Croucher, P, وآخرون
منشور في: (2000)

Bisphosphonates--mechanisms of action in multiple myeloma.
حسب: Shipman, C, وآخرون
منشور في: (2000)

Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma
حسب: Fengjuan Jiang, وآخرون
منشور في: (2021-08-01)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
حسب: Croucher, P, وآخرون
منشور في: (2003)

The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease
حسب: Jing Fu, وآخرون
منشور في: (2023-07-01)

TRPV2-induced Ca2+-calcineurin-NFAT signaling regulates differentiation of osteoclast in multiple myeloma
حسب: Hua Bai, وآخرون
منشور في: (2018-10-01)

BISPHOSPHONATES AFFECT HUMAN OSTEOCLAST DEVELOPMENT IN VITRO
حسب: Mabilleau, G, وآخرون
منشور في: (2010)

Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.
حسب: Vanderkerken, K, وآخرون
منشور في: (2003)

Osteoclasts in myeloma are derived from Gr-1+CD11b+mononuclear cells of the bone marrow niche
حسب: Zhuang, J, وآخرون
منشور في: (2007)

Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells
حسب: Zhuang, J, وآخرون
منشور في: (2012)

Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids
حسب: Xu, K, وآخرون
منشور في: (2009)

Multi-Scale Agent-Based Multiple Myeloma Cancer Modeling and the Related Study of the Balance between Osteoclasts and Osteoblasts.
حسب: Minna Qiao, وآخرون
منشور في: (2015-01-01)

A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts.
حسب: Maiko Matsushita, وآخرون
منشور في: (2015-01-01)

Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells.
حسب: Junling Zhuang, وآخرون
منشور في: (2012-01-01)

In vitro generation of mature human osteoclasts.
حسب: Hemingway, F, وآخرون
منشور في: (2011)

In vitro generation of mature human osteoclasts.
حسب: Hemingway, F, وآخرون
منشور في: (2011)

The Effects of Forodesine in Murine and Human Multiple Myeloma Cells
حسب: Liesbeth Bieghs, وآخرون
منشور في: (2010-01-01)

Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
حسب: Kudo, O, وآخرون
منشور في: (2002)

Effect of amorphous silica nanoparticles on <it>in vitro </it>RANKL-induced osteoclast differentiation in murine macrophages
حسب: Nagano Kazuya, وآخرون
منشور في: (2011-01-01)

Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.
حسب: Matilda H-C Sheng, وآخرون
منشور في: (2012-01-01)

Osteoclasts and Microgravity
حسب: John Kelly Smith
منشور في: (2020-09-01)

Estrogen receptor gene expression in osteoclasts loss with osteoclast maturation.
حسب: Oreffo, R, وآخرون
منشور في: (1997)

Osteoclast Activation and Inflammatory Bone Diseases: Focusing on Receptors in Osteoclasts
حسب: Zhao W, وآخرون
منشور في: (2025-03-01)